Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
9 Meters Biopharma Inc (NMTR)  
$0.00 0.00 (0.00%) as of 4:30 Thu 3/28


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 12,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.000001 - $0.81
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   9 Meters Biopharma is a clinical-stage company. Co.'s product development pipeline include: Vurolenatide, which is a long-acting glucagon-like peptide-1 receptor agonist that combines exenatide with a proprietary extended half-life technology for treatment of short bowel syndrome; Larazotide, which is being developed for the treatment of celiac disease; NM-102, which is a small molecule peptide that is being developed as a potential microbiome modulator and is undergoing an indication selection process; and NM-003, which is a proprietary long-acting glucagon-like peptide-2 agonist with improved serum half-life compared with short-acting versions.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 472,383
Total Buy Value $0 $0 $0 $151,319
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 5
Total Shares Sold 0 0 0 9,100
Total Sell Value $0 $0 $0 $11,011
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 110
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Barre Steven C Director   –       •      –    2016-11-16 4 A $0.00 $0 D/D 10,000 10,000     -
   Clarke David H Former CEO and Director   •       •      –    2016-07-13 4 B $4.50 $67,500 D/D 15,000 445,043 2.81     -
   Clark Jonathan P Director   –       •      –    2016-07-07 4 A $0.00 $0 D/D 10,000 10,000     -
   Olert David Lewis CFO   •       –      –    2016-07-07 4 A $0.00 $0 D/D 25,000 25,000     -
   Tandon Jawahar Chairman of the Board   •       •      –    2016-07-07 4 A $0.00 $0 D/D 125,000 125,000     -
   Tandon Vivek EVP - Operations   •       –      –    2016-07-07 4 A $0.00 $0 D/D 25,000 25,000     -
   Orban Jonathan S Director   –       •      –    2016-07-07 4 A $0.00 $0 D/D 10,000 10,000     -
   Matejka Marc S VP - Operations   •       –      –    2016-07-07 4 A $0.00 $0 D/D 25,000 25,000     -
   Machinist Robert Director   –       •      –    2016-07-07 4 A $0.00 $0 D/D 10,000 10,000     -
   Miner Christopher Michael Director   –       •      –    2016-07-07 4 A $0.00 $0 D/D 10,000 10,000     -

  110 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed